Registered entities
Cymabay Therapeutics, Inc.
Reg. No. 10254168United States
CYMABAY THERAPEUTICS, INC.
Reg. No. 943103561United States
Innovation
48 patent families (28 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 5,497 times.
| Year | Filings |
|---|---|
| 2015 | 19 |
| 2016 | 13 |
| 2017 | 17 |
| 2018 | 12 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 12 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 6 |
| 2026 | 3 |
Investor mix
26 investors on record; lead investors include KBC Private Equity, Pictet Group, Next Chapter Holdings, Charter Life Sciences; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 46% |
| Private equity | 2 | 8% |
| Bank & private debt | 4 | 15% |
| Other / undisclosed | 8 | 31% |